Industry News

Advanced Composite Structures Australia (ACS Australia) has partnered with Carnegie Clean Energy together as participants of the Blue Economy Cooperative Research Centre (Blue Economy CRC) to develop the future of renewable energy power generation using the untapped wave energy source of the world’s oceans. Wave energy is consistent, predictable and globally distributed, and can be converted into clean, renewable electricity. For offshore aquaculture, the use of wave energy means less reliance on conventional fuels and a chance to decarbonise operations in remote locations, like barges. Ocean Energy Europe (OEE) forecasts significant growth for wave energy with a $1.09Tn market potential by 2050. Carnegie Clean Energy, based in North Fremantle, Western Australia, develops ocean energy technologies including their wave energy converter (WEC), the CETO® targeting utility-scale power, and artificial intelligence wave predictor technology to capture the most energy out of every wave. Together with Blue Economy CRC partners, they are developing the next generation of wave energy converters, and the key to this development is the Mooring Tensioner Wave Energy Converter (MoTWEC). The ACS Australia team members are composites specialists responsible for the engineering design,…

Leading renewable energy developer ACEnergy is setting its sights on a portfolio of distribution scale Battery Energy Storage Systems (BESS) as it seeks to expand its project range and support regional communities. The company is also calling for industry collaboration to introduce reforms that will expedite the rollout of renewable energy projects that are critical to the transition to net zero. ACEnergy has assembled an expert team across the development value chain; from land acquisition to grid connection and operation and maintenance, and often holds the assets it develops for the long term. This approach means ACEnergy becomes part of the communities in which it operates, working with local suppliers and providing job opportunities to local people. The initial 50MW/100MWh distribution battery portfolio is currently undergoing planning studies, with sites selected across Victoria and NSW. ACEnergy intends to retain ownership and operate the assets over their life. ACEnergy has picked locations where BESS can work in concert with local grid demand. By coordinating their operation according to the local network demand profile, the distributed BESS will increase network capacity, alleviating curtailment…

Carbitool, known as “The Woodworking Masters,” is a company based in Australia that has been manufacturing carbide tools for the woodworking, cabinetry, joinery, furniture, timber, and panel industries for over 60 years. In 2018, Sutton Tools acquired Carbitool and now offers its services worldwide. Production Supervisor and regrind specialist, Michael Wilson, has over 25 years of experience in manufacturing and grinding special cutting tools at Carbitool. According to Wilson, Carbitool services all kinds of tooling, including metal cutting tools, woodworking tools, high-speed steel tools, carbide tools, and PCD tools. The company can also regrind all major brands of cutting tools and manufacture custom tools that are not available in the catalogue. Carbitool's services cater to various industries, such as aerospace, engineering, plastics, and more, and are available throughout Australia. “We pride ourselves on the quality of the regrinds but I also feel it's important to the customers that they have a quick turnaround of the tools,” said Wilson. “Previously what we've had to do is they would either get hand loaded during the day - so you can regrind one tool, and write the…

In the medical manufacturing industry, ensuring the highest standards of quality and safety is of utmost importance. One critical aspect of this industry is the use of compressed air systems. Oil-free compressors have emerged as a necessity due to their ability to maintain cleanliness and purity, essential for various medical applications. Maintaining Air Purity: Compressed air is extensively utilised in medical manufacturing processes, including pneumatic tools, air-powered machinery, and cleanroom environments. Oil-free compressors play a vital role in maintaining the purity of the compressed air used in these applications. Unlike traditional compressors that employ lubricating oil, oil-free compressors prevent the risk of oil contamination, ensuring a clean and sterile working environment. This is particularly crucial for medical manufacturing, where any trace of oil in the air supply can have detrimental effects on product quality and patient safety. Product Quality and Safety: Medical devices and equipment require uncompromising quality standards to ensure their effectiveness and safety. Oil-free compressors eliminate the risk of oil particles entering the compressed air, which could potentially contaminate sensitive components during manufacturing. By minimising the possibility of oil-induced defects or…

Tasmanian manufacturer Sea Forest is ready to take the equivalent of hundreds of thousands of cars off the road and help the red meat industry meet its net zero goals through support from the AMGC and a unique Australian species of seaweed. The seaweed asparagopsis armata has been known to have giant methane-busting potential when added in tiny quantities as a supplement for ruminant animals. Thanks to a collaborative project led by Sea Forest and aided by $675,000 in co-investment from AMGC, the company now boasts a state-of-the-art manufacturing facility at its Triabunna headquarters. “This is a great Australian idea that has now been turned into a successful commercial business via manufacturing. Through the commercialisation process, Sea Forest has developed a local product with global potential, while generating jobs and supporting global moves to reduce emissions,” said Dr. Jens Goennemann, Managing Director, AMGC. The $3.2m project took just over 18 months to complete and has created nine full-time roles and upskilled a further eight staff at Sea Forest, which has been growing seaweed at Triabunna, Tasmania since 2019. Over the coming…

Recent months have seen increased discussion on the growth of Australian research and development (R&D), with research agencies, universities and the government agreeing there is a need for greater investment in the sector. The pharmaceutical industry is one of the biggest contributors to research and development in the country and is currently a burgeoning market. This puts it in a prime position to build Australia's R&D capacity. According to the latest government figures, R&D expenditure in Australia is 1.8% of GDP, which is below the OECD average of 2.67%. Government spending specifically has been declining over the years, with an average of 0.61% of GDP since 2010-11, and only 0.17% in 2020-21. It is worth noting that Australia is currently ranked 91st on the global Economic Complexity Index, while countries in the top 10, such as Japan, Germany and the United States, all spend more than 3% of their GDP on R&D, and are considered world leaders in research. Ahead of the 2022 election, Labor pledged to work towards spending “closer to…

Coherent Corporation, a global leader in ceramics and metal matrix composites, has announced that it has developed an additive manufacturing process capable of producing advanced ceramic components for high-performance thermal management applications, including for next-generation semiconductor capital equipment. Severe shortages of integrated circuits based on leading-edge nodes have spurred massive investments worldwide in the buildout of semiconductor manufacturing facilities equipped with the most advanced semiconductor capital equipment. Coherent has successfully developed proprietary materials and technologies that enable ceramic components produced with its additive manufacturing process to match those produced with its existing molding process in their mechanical and thermal properties. Ceramic components manufactured with the new additive manufacturing process can now be precision-machined using the most advanced laser-based techniques, including those available at Coherent. These are critical for next-generation semiconductor capital equipment. Additive manufacturing is superior to molding in process capability, yield, and throughput. It requires no retooling time between components, which minimizes lead times and waste. As such, additive manufacturing is ideal for Industry 4.0 factories that are designed for resilient and flexible scaling. “Ceramic additive manufacturing enables…

The newest round of the Innovate to Grow program, coordinated by Australia’s national science agency CSIRO, will equip small to medium-sized enterprises (SMEs) in the cyber security and digital technology sectors with critical research and development (R&D) know-how to grow their businesses. CSIRO’s Innovate to Grow program links businesses to expert knowledge, resources, and mentors to help businesses validate, and develop their R&D ideas that could lead to commercial outcomes. On completing the program, eligible participants can apply to work with CSIRO’s expert researchers and access dollar-matched R&D funding through the Kickstart program. Dr Marthie Grobler, Principal Research Scientist in human-centred cyber security at CSIRO’s Data61 strongly urged eligible businesses to consider applying to stay at the forefront of research impact in these critical sectors. “SMEs are the lifeblood of Australia, and many have innovative business ideas and solutions that could help mitigate cyber security threats and deliver a positive impact to other Australian businesses and the economy,” Dr Grobler said. “These businesses tend to face a myriad of challenges in bringing their ideas to life, namely investment of money, time and resources.…

Clinical-stage biotechnology company Vaxxas, in partnership with the Queensland Government, opened its global headquarters and state-of-the-art manufacturing facility this June in Brisbane. The custom-built 5,500m² Vaxxas Biomedical Facility is a first-of-its-kind manufacturing site, designed to support the scale-up of Vaxxas’ needle-free vaccine technology platform, the high-density microarray patch (HD-MAP), for late-stage clinical trials and first commercial products. AMT spoke to Vaxxas’ Chief Technology Officer, Dr. Angus Forster, the day after the new facility opened. “It’s been an exciting couple of weeks and it was an excellent day yesterday. Queensland’s Deputy Premier, Dr Steven Miles opened the facility and we had around 80 invited guests from industry in attendance.” Vaxxas’ new facility is located in Brisbane’s Northshore and the company was previously based at the Translational Research Institute (TRI) at the Princess Alexandra Hospital Campus in Brisbane’s inner suburbs. “We are still keeping a presence at the TRI for its pre-clinical infrastructure, while our new facility is focused on manufacturing our vaccine patches for late-stage clinical trials and commercial product. It's great to still be connected with the vibrant TRI research community, as there…

Leading photo-chemical etching (PCE) innovator, micrometal, has demonstrated the power of its next-generation precision metal processing technology following some recent work with a manufacturer of ophthalmic devices incorporating surgical blades. PCE offers several specific advantages when it comes to manufacturing intricate blades for eye surgery. Firstly, it allows for the creation of extremely precise and intricate blade designs with sharp edges and tight tolerances, ensuring the highest level of accuracy and consistency during surgery. This is particularly important for eye surgery, where even small variations in blade design can have a significant impact on patient outcomes. Secondly, PCE can produce very thin blades, down to a few microns in thickness, which are required for many types of eye surgeries. These blades can be manufactured with no burrs or rough edges, ensuring smooth and precise cutting. In addition, the PCE process is a chemical, non-contact process, which means that there is no physical force applied to the metal during manufacturing, reducing the risk of deformation or damage to the blade. This is particularly important when working with thin, delicate blades that require extreme precision. “For…

New purpose-built equipment added to Melbourne and San Diego facilities will help with clinical scale and global capacity shortages PCI Pharma Services (PCI), a leading global contract development and manufacturing organisation (CDMO), has announced the operational launch of three new state-of-the-art automated sterile fill-finish machines at its Melbourne and San Diego facilities. “As the capacity for CDMOs worldwide to take on new projects shrinks, we’re excited to be able to offer integrated sterile fill-finish capabilities, alongside our clinical packaging facilities, to new and existing clients in Melbourne and San Diego,” said Brad Payne, Chief Operating Officer, PCI Pharma Services. “Our increased capacity, a stockpile of standardised components, including glass, and technical expertise means we can start running batches as soon as needed. This will cut down on the wait times many local biotech and pharmaceutical companies are facing and begin to help alleviate the global capacity shortage for sterile drug product and downstream packaging.” The new innovative machinery from Cytiva can be used to fill various sterile medications into vials and syringes for small-to-mid-scale client needs. The equipment, paired with PCI’s end-to-end services,…

Pacific Automation has announced a new Australian partnership with German manufacturer BERNSTEIN. This new national distribution deal makes BERNSTEIN switching safety and innovation available to all Australian industrial operators, along with technical support provided by Pacific Automation. “We’ve been supplying BERNSTEIN products since 2006, so our team is well familiarised with the quality of their products,” says Stephen Armstrong, CEO at Pacific Automation. “Our goal is to represent BERNSTEIN in Australia how they would represent themselves. That means ensuring that our customers receive high-quality customer service and technical support, just like they would from an OEM.” Key product ranges now accessible through this new partnership include: Limit switches • Door interlock switches • Safety rope pull switches. • Foot switches BERNSTEIN switches are utilised in factory automation and for machine and operator safety across the Australian industry. Their products are highly modular and can often be customised to suit the requirements of an individual customer or unique application. “We intend to keep growing and distribute our products around the globe. Therefore, we are pleased to have found a partner like Pacific…

As part of its successful transformation from a photographic film manufacturer to a company contributing to resolving social challenges with advanced technologies in a wide range of business fields, Fujifilm Australia has now further expanded its range of cutting-edge Artificial Intelligence (AI) solutions into the healthcare industry – one of its core businesses. Fujifilm’s latest foray into the AI sphere is in partnership with Australian-based medical imaging specialists annalise.ai and their CXR Edge solution, one of the world’s leading and comprehensive chest X-ray AI decision-support solutions for mobile and fixed X-ray devices. “Fujifilm has been supplying X-ray film to the healthcare industry since 1936, shortly after the foundation of Fujifilm in Japan,” explains Ryuichi Matoba, CEO of Fujifilm Australia. “Since then, Fujifilm has expanded its Medical Systems business with some significant milestones along the way, such as developing Fuji Computed Radiography, applying the world’s first digital method for digitising X-ray images. In short, Fujifilm wants to create a society where people can live healthily for longer and Fujifilm’s AI technology and our new partnership with annalise.ai both play a…